Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

This study has been completed.
Beth Israel Deaconess Medical Center
Medstar Research Institute
Medidata Solutions
Information provided by (Responsible Party):
Boston Scientific Corporation Identifier:
First received: January 16, 2013
Last updated: October 24, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)